9 Results for "

activated factor XI

" in MedChemExpress (MCE) Product Catalog:
Products (9)

9 Results for "activated factor XI" in MCE Product Catalog:

9
9 Cited Publications
Cat. No.: HY-114164H
CAS No.: 9002-04-4
Synonyms: EC 3.4.21.5 (Lyophilized); Human Alpha Thrombin (Lyophilized)
Human α-Thrombin (EC 3.4.21.5; Human Alpha Thrombin) (Lyophilized) is a terminal serine protease in the coagulation cascade, as well as a potent physiological platelet agonist and fibrin-generating enzyme in vivo. Human α-Thrombin catalyzes the conversion of fibrinogen to fibrin for blood clot formation, and activates platelet aggregation by cleaving the protease-activated receptors PAR1 (major) (Kd = 1 nM) and PAR4 (minor) on the platelet surface to expose tethered ligands. Human α-Thrombin also amplifies coagulation via positive feedback by activating coagulation factors V, VIII, XI (FV/FVIII/FXI), and switches to activate protein C to exert anticoagulant effects after binding to thrombomodulin .
This product is in a freeze-dried form.
loading...
    loading...
Cat. No.: HY-156613
CAS No.: 1803270-60-1
Purity:  97.16%
Synonyms: EP-7041
Target:  

Factor XI

Research Areas:  

Cardiovascular Disease

Frunexian (EP-7041) is a small-molecule activated factor XI (FXIa) inhibitor. Frunexian has the characteristics of rapid onset and offset of action, a short half-life, dose-dependent prolongation of activated partial thromboplastin time, and an extremely low risk of bleeding. Frunexian exhibits good safety and tolerability and can be used in research related to thrombocytopenia, thromboembolism, thromboembolic diseases, and COVID-19 .
loading...
    loading...
Cat. No.: HY-175735
CAS No.: 2563884-39-7
Target:  

Factor XI

Research Areas:  

Cardiovascular Disease

Factor XI-IN-2 is a Factor XI activation inhibitor with an IC50 of 20 nM. Factor XI-IN-2 does not directly inhibit the enzymatic activity of FXIa, but specifically binds to the FXI enzyme precursor and allosterically inhibits the process by which it is activated by FXIIa. Factor XI-IN-2 inhibits thrombosis in the rabbit arteriovenous (AV) shunt thrombosis model. Factor XI-IN-2 can be used for the study of antithrombus .
loading...
    loading...
Cat. No.: HY-107966A
CAS No.: 37270-89-6
Synonyms: Nadroparin calcium (MW 3600-5000)
Heparin (Nadroparin) calcium (MW 3600-5000) is an anticoagulant which binds reversibly to antithrombin III (ATIII) to form a heparin-antithrombin III complex. The complex binds to and irreversibly inactivates thrombin and other activated clotting factors IX, X, XI, and XII and prevents the transformation of fibrinogen to fibrin .
loading...
    loading...
Cat. No.: HY-143477
CAS No.: 2720619-72-5
Research Areas:  

Cardiovascular Disease

Factor XI-IN-1 is an activator inhibitor of coagulation factor XI (Factor XI) with an EC50 of 25.14 nM. Factor XI-IN-1 is applicable to research related to thrombosis, embolism, hypercoagulable states and fibrotic changes .
loading...
    loading...
Cat. No.: HY-151196
CAS No.: 2816108-08-2
Target:  

Factor Xa

Research Areas:  

Cardiovascular Disease

FXIa-IN-10 (Compound 3f) is a potent activated factor XI (FXIa) inhibitor with an Ki of 0.17 nM. FXIa-IN-10 has good oral bioavailability .
loading...
    loading...
Cat. No.: HY-107966
CAS No.: 37270-89-6
Synonyms: Nadroparin calcium (MW 15000-19000)
Heparin calcium (MW 15000-19000) is an anticoagulant which binds reversibly to antithrombin III (ATIII) to form a heparin-antithrombin III complex. The complex binds to and irreversibly inactivates thrombin and other activated clotting factors IX, X, XI, and XII and prevents the transformation of fibrinogen to fibrin .
loading...
    loading...
Cat. No.: HY-156613A
CAS No.: 2416857-24-2
Synonyms: EP-7041 hydrochloride
Target:  

Factor XI

Research Areas:  

Cardiovascular Disease

Frunexian (EP-7041) hydrochloride is a small-molecule activated factor XI (FXIa) inhibitor. Frunexian hydrochloride has the characteristics of rapid onset and offset of action, a short half-life, dose-dependent prolongation of activated partial thromboplastin time, and an extremely low risk of bleeding. Frunexian hydrochloride exhibits good safety and tolerability and can be used in research related to thrombocytopenia, thromboembolism, thromboembolic diseases, and COVID-19 .
loading...
    loading...
Cat. No.: HY-183409
CAS No.: 1941243-22-6
Synonyms: ONO-5450598
Target:  

Factor Xa

Research Areas:  

Cardiovascular Disease

ONO-7684 (ONO-5450598) is an orally active coagulation factor XIa (FXIa) inhibitor with a Ki value of 2 nM against human FXIa. ONO-7684 inhibits human FXIa in a competitive and reversible manner, reduces factor XI coagulation activity, prolongs activated partial thromboplastin time in a dose-dependent manner, and exerts no significant effects on PT/INR and the activity of related serine proteases. ONO-7684 exerts antithrombotic effects in vivo without prolonging bleeding time. ONO-7684 can be used in studies related to thromboembolic diseases .
loading...
    loading...